COVID A
UTHORS
Online profiles of coronavirus experts
Return to Top
Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID-19.
Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID-19. Dermatol Ther. 2021 11; 34(6):e15111.
View in:
PubMed
subject areas
Anti-Allergic Agents
Chronic Disease
Humans
Omalizumab
Treatment Outcome
Urticaria
authors with profiles
Maddalena Napolitano
Gabriella Fabbrocini
Cataldo Patruno
Luigi Bennardo
Stefano Dastoli
Steven Paul Nisticò
Maria Passante